Home › Markets › Health Care › TNDM

Tandem Diabetes Care Inc. (TNDM)

TNDM trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$16.65
+1.22% on the day
Market cap
$1.2B
Small cap
Revenue · 2025
$1.0B
+7.9% on 2024
Net income · 2025
-$204.7M
-20.2% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.

Profile

FieldValue
TickerTNDM on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO year2013
SEC CIK0001438133
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$1.0B
Net income-$204.7M
Operating income-$187.3M
Net margin-20.2%
Operating margin-18.5%
Revenue growth+7.9%
Cash$90.6M
Total assets$881.1M
P/E (computed)Net income was not positive
P/S (computed)1.1×

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
424B5 PROSPECTUS 08-2018
424B52018-08-03
Latest annual report10-K2026-02-19
Latest quarterly / interim10-Q2026-08-06
Latest current report8-K2026-08-06
Latest proxyDEFA14A2026-04-07

Source: SEC EDGAR submissions feed, 1,001 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+1.9%
1 month-0.9%
3 months-0.9%
Year to date-26.6%
1 year+16.4%
From 52-week high-42.9%

Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
IRMDiRadimed Corporation$89.65+0.20%$1.1B
BVSBioventus Inc.$13.56+0.22%$1.1B
PRCTPROCEPT BioRobotics Corporation$19.10-2.40%$1.1B
IARTIntegra LifeSciences Holdings Corporation$13.85-0.93%$1.1B
DRTSAlpha Tau Medical Ltd.$13.74-3.65%$1.3B
AORTArtivion Inc.$21.36-1.97%$1.0B
BBNXBeta Bionics Inc.$17.69-0.95%$931.2M
SIBNSI-BONE Inc.$19.68-2.09%$882.0M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier